Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-9f2xs Total loading time: 0 Render date: 2025-03-04T01:10:35.748Z Has data issue: false hasContentIssue false

1 - Epidemiology of hepatocellular carcinoma and cholangiocarcinoma

Published online by Cambridge University Press:  04 August 2010

By
Jorge A. Marrero
Edited by
Hero K. Hussain  and
Isaac R. Francis
Hero K. Hussain
Affiliation:
University of Michigan Medical School, Ann Arbor
Isaac R. Francis
Affiliation:
University of Michigan Medical School, Ann Arbor
Get access

Summary

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third cause of cancer-related deaths worldwide. Cholangiocarcinoma (CCA) is the second most common primary liver tumor and is less common than HCC. The latest data from the Surveillance, Epidemiology and End Results (SEER) program, a population-based study on cancer incidence, prevalence, and mortality in the United States, show that primary liver cancer (90% HCC and 10% CCA) is one of few tumors with a rising incidence over the last 10 years (Figure 1.1). We herein discuss the epidemiology and risk factors for these tumors.

Hepatocellular carcinoma

The largest concentration of HCC cases in the world is in Asia, followed by Africa, Europe, and North and South America. The incidence of HCC varies among ethnic groups, with increasing incidence rates found in Japanese (5.5/100 000 in men and 4.3/100 000 in women), African American (7.1/100 000 in men and 2.1/100 000 in women), Hispanic (9.8/100 000 in men and 3.5/100 000 in women), and Chinese (16.2/100 000 in men and 5/100 000 in women) populations. Even though the incidence rate is greater in men compared to women, there is a 2- to 5-fold higher incidence rate among women of various ethnicities compared to non-Hispanic white women. During the last two decades, an increasing trend in the incidence of HCC has been noted in Australia, Central Europe, the United Kingdom, Japan, and North America.

Type
Chapter
Information
Primary Carcinomas of the Liver , pp. 1 - 9
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Parkin, DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533–43.CrossRefGoogle ScholarPubMed
El-Serag, HB. Global epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001; 5: 87–107.CrossRefGoogle Scholar
Bosch, FX, Ribes, J, Diaz, M, and Cleries, R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127: S5–S16.CrossRefGoogle ScholarPubMed
El-Serag, HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004; 127: S7–S34.CrossRefGoogle ScholarPubMed
Beasley, RP, Hwang, LY, Lin, CC, and Chien, CS. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan. Lancet 1981; 2: 1129–33.CrossRefGoogle ScholarPubMed
El-Serag, HB, Davila, JA, Petersen, NJ, and McGlynn, KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Ann Intern Med 2003; 139: 117–23.CrossRefGoogle ScholarPubMed
Davila, J, Morgan, R, Shaib, Y, McGlynn, KA, and El-Serag, HB. Hepatitis C infection and the rising incidence of hepatocellular carcinoma: A population-based study. Gastroenterology 2004; 127: 1372–80.CrossRefGoogle Scholar
Fattovich, G, Stroffolini, T, Zagni, I, and Donato, F. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 2004; 127: S35–S50.CrossRefGoogle ScholarPubMed
Niederau, C, Lange, C, Heintges, T, et al. Prognosis of hepatitis C: Results of a large, prospective cohort study. Hepatology 1998; 28: 1687–95.CrossRefGoogle ScholarPubMed
El Serag, HB and Mason, AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160: 3227–30.CrossRefGoogle ScholarPubMed
Marrero, JA, Fontana, RJ, Su, GL, Conjeevaram, HS, Emick, DM, and Lok, AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002; 36: 1349–54.CrossRefGoogle ScholarPubMed
El-Serag, HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001; 5: 87–107.CrossRefGoogle ScholarPubMed
Deugnier, Y and Turlin, B. Iron and hepatocellular carcinoma. J Gastroenterol Hepatol 2001; 16: 491–4.CrossRefGoogle ScholarPubMed
Farinati, F, Floreani, A, Maria, N, Fagiuoli, S, Naccarato, R, and Chiaramonte, M. Hepatocellular carcinoma in primary biliary cirrhosis. J Hepatol 1994; 21: 315–16.CrossRefGoogle ScholarPubMed
Nishiyama, R, Kanai, T, Abe, J, et al. Hepatocellular carcinoma associated with autoimmune hepatitis. J Hepatobiliary Pancreat Surg 2004; 11: 215–19.CrossRefGoogle ScholarPubMed
Carbonell, N, Pauwels, A, Serfaty, L, Fourdan, O, Levy, VG, and Poupon, R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652–9.CrossRefGoogle ScholarPubMed
Hassan, MM, Frome, A, Patt, YZ, and El-Serag, HB. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 2002; 35: 266–9.CrossRefGoogle ScholarPubMed
Yang, HI, Lu, SN, Liaw, YF, et al. Taiwan Community-Based Cancer Screening Project Group: Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168–74.CrossRefGoogle ScholarPubMed
Chen, CJ, Yang, HI, Su, J, et al. REVEAL-HBV Study Group: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65–73.CrossRefGoogle Scholar
Chan, HL, Tse, CH, Mo, F, et al. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol 2008; 26: 177–82.CrossRefGoogle ScholarPubMed
Donato, F, Tagger, A, Gelatti, U, et al. Alcohol and hepatocellular carcinoma: The effect of lifetime intake and viral hepatitis infection in men and women. Am J Epidemiol 2002; 155: 323–31.CrossRefGoogle ScholarPubMed
El-Serag, HB, Marrero, JA, Rudolph, L, and Reddy, KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752–63.CrossRefGoogle ScholarPubMed
Calle, EE, Rodriguez, C, Walker-Thurmond, K, and Thun, MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625–38.CrossRefGoogle Scholar
Wang, LY, Hatch, M, Chen, CJ, et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer 1996; 67: 620–5.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
El-Serag, HB, Tran, T, and Everhart, JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460–8.CrossRefGoogle ScholarPubMed
Marrero, JA, Fontana, RJ, Fu, S, Conjeevaram, HS, Su, GL, and Lok, AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005; 42: 218–24.CrossRefGoogle ScholarPubMed
Tanaka, Y, Hanada, K, Mizokami, M, et al. Inaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 2002; 99: 15584–9.CrossRefGoogle Scholar
Singal, A and Marrero, JA. Screening for hepatocellular carcinoma. Gastroenterol Hepatol 2008; 4: 201–8.Google Scholar
Groen, PC, Gores, GJ, LaRusso, NF, et al. Biliary tract cancers. N Engl J Med 1999; 341: 1368–78.CrossRefGoogle ScholarPubMed
Goldzieher, M and Bokay, Z. Der primaere leberkrebs. Virchows Arch 1911; 203: 75–131.CrossRefGoogle Scholar
Klatskin, G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241–56.CrossRefGoogle ScholarPubMed
Patel, T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353–7.CrossRefGoogle ScholarPubMed
Shaib, YH, Davila, JA, McGlynn, K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: A true increase?J Hepatol 2004; 40: 472–7.CrossRefGoogle ScholarPubMed
Mouzas, IA, Dimoulios, P, Vlachonikolis, IG, Skordilis, P, Zoras, O, and Kouroumalis, E. Increasing incidence of cholangiocarcinoma in Crete 1992–2000. Anticancer Res 2002; 22: 3637–41.Google ScholarPubMed
Okuda, K, Nakanuma, Y, and Miyazaki, M. Cholangiocarcinoma: Recent progress. Part 1. Epidemiology and etiology. J Gastroenterol Hepatol 2002; 17: 1049–55.CrossRefGoogle ScholarPubMed
Welzel, TM, McGlynn, KA, Hsing, AW, et al. Impact of classification of hilar cholangiocarcinoma (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006; 98: 873–5.CrossRefGoogle ScholarPubMed
Patel, T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002; 2: 1–5.CrossRefGoogle ScholarPubMed
McLean, L and Patel, T. Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver Int 2006; 26: 1047–53.CrossRefGoogle ScholarPubMed
Burak, K, Angulo, P, Pasha, TM, Egan, K, Petz, J, and Lindor, KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004; 99: 523–6.CrossRefGoogle ScholarPubMed
Bergquist, A, Ekbom, A, Olsson, R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36: 321–7.CrossRefGoogle ScholarPubMed
Watanapa, P and Watanapa, WB. Liver fluke-associated cholangiocarcinoma. Br J Surg 2002; 89: 962–70.CrossRefGoogle ScholarPubMed
Kurathong, S, Lerdverasirikul, P, Wongpaitoon, V, et al. Opisthorchis viverrini infection and cholangiocarcinoma: A prospective, case-controlled study. Gastroenterology 1985; 89: 151–6.CrossRefGoogle ScholarPubMed
Kubo, S, Kinoshita, H, Hirohashi, K, et al. Hepatolithiasis associated with cholangiocarcinoma. World J Surg 1995; 19: 637–41.CrossRefGoogle ScholarPubMed
Lesurtel, M, Regimbeau, JM, Farges, O, Colombat, M, Sauvanet, A, and Belghiti, J. Intrahepatic cholangiocarcinoma and hepatolithiasis: An unusual association in Western countries. Eur J Gastroenterol Hepatol 2002; 14: 1025–7.CrossRefGoogle ScholarPubMed
Su, CH, Shyr, YM, Lui, WY, et al. Hepatolithiasis associated with cholangiocarcinoma. Br J Surg 1997; 84: 969–73.CrossRefGoogle ScholarPubMed
Chapman, RW. Risk factors for biliary tract carcinogenesis. Ann Oncol 1999; 10: S308–S311.CrossRefGoogle ScholarPubMed
Lipsett, PA, Pitt, HA, Colombani, PM, et al. Choledochal cyst disease: A changing pattern of presentation. Ann Surg 1994; 220: 644–52.CrossRefGoogle ScholarPubMed
Scott, J, Shousha, S, Thomas, HC, et al. Bile duct carcinoma: A late complication of congenital hepatic fibrosis. Case report and review of literature. Am J Gastroenterol 1980; 73: 113–19.Google ScholarPubMed
Change, KY, Chang, JY, Yen, Y. Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. J Natl Compr Canc Netw 2009; 7: 423–7.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×